HCA Healthcare - HCA Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $310.88
Forecasted Upside: 1.39%
Number of Analysts: 15
Breakdown:
0 Sell Ratings
4 Hold Ratings
11 Buy Ratings
0 Strong Buy Ratings

^$306.60 As of 04/26/2024 01:00 AM ET

▼ -7.52 (-2.39%)

1 month | 3 months | 12 months

Get New HCA Healthcare Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for HCA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCA

^$310.88

▲ +1.39% Upside Potential

This price target is based on 15 analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $310.88, with a high forecast of $359.00 and a low forecast of $265.00. The average price target represents a 1.39% upside from the last price of $306.60.

Current Consensus is Moderate Buy

The current consensus among 15 investment analysts is to moderate buy stock in HCA Healthcare. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

11/2/2022

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/31/2023

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

5/1/2023

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

7/30/2023

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

10/28/2023

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

1/26/2024

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

3/26/2024

0 strong buy ratings
11 buy ratings
4 hold ratings
0 sell ratings

Ratings as of

4/25/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/12/2024	Deutsche Bank Aktiengesellschaft	Boost Target	Buy ➝ Buy	$330.00 ➝ $359.00	Low
4/10/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$335.00	Low
3/28/2024	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$303.00 ➝ $315.00	N/A
3/6/2024	Barclays	Initiated Coverage	Overweight	$356.00	Low
3/5/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$335.00	Low
1/31/2024	Truist Financial	Boost Target	Buy ➝ Buy	$320.00 ➝ $345.00	Low
1/31/2024	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$308.00 ➝ $322.00	Low
1/31/2024	Raymond James	Boost Target	Outperform ➝ Outperform	$300.00 ➝ $330.00	Low
1/24/2024	Raymond James	Boost Target	Outperform ➝ Outperform	$280.00 ➝ $300.00	Low
1/19/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$315.00	Low
1/17/2024	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$315.00	Low
1/4/2024	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform	$277.00 ➝ $301.00	Low
12/11/2023	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$271.00	Low
11/17/2023	JPMorgan Chase & Co.	Lower Target	Neutral ➝ Neutral	$313.00 ➝ $265.00	Low
11/10/2023	Stephens	Reiterated Rating	Overweight ➝ Overweight	$280.00	Low
10/30/2023	The Goldman Sachs Group	Lower Target	Buy ➝ Buy	$329.00 ➝ $281.00	Low
10/26/2023	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$267.00 ➝ $254.00	Low
10/25/2023	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$315.00 ➝ $284.00	Low
10/25/2023	Truist Financial	Lower Target	Buy ➝ Buy	$340.00 ➝ $300.00	Low
10/25/2023	Mizuho	Lower Target	Buy ➝ Buy	$325.00 ➝ $275.00	Low
10/25/2023	Citigroup	Lower Target	Buy ➝ Buy	$324.00 ➝ $279.00	Low
10/25/2023	Stephens	Lower Target	Overweight ➝ Overweight	$300.00 ➝ $280.00	Low
10/25/2023	Raymond James	Lower Target	Outperform ➝ Outperform	$320.00 ➝ $280.00	Low
10/20/2023	Wells Fargo & Company	Lower Target	Equal Weight ➝ Equal Weight	$275.00 ➝ $267.00	Low
10/10/2023	Sanford C. Bernstein	Lower Target		$345.00 ➝ $294.00	Low
9/14/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$315.00	Low
9/13/2023	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$315.00	Low
7/28/2023	Credit Suisse Group	Boost Target	Outperform	$311.00 ➝ $316.00	Low
7/28/2023	Oppenheimer	Boost Target	Outperform	$310.00 ➝ $315.00	Low
7/11/2023	Mizuho	Boost Target		$305.00 ➝ $325.00	Low
6/28/2023	1-800-FLOWERS.COM	Reiterated Rating	Maintains		Low
6/28/2023	VNET Group	Reiterated Rating	Maintains		Low
6/28/2023	Barclays	Boost Target		$275.00 ➝ $300.00	Low
6/20/2023	Truist Financial	Boost Target		$325.00 ➝ $340.00	Low
5/16/2023	Mizuho	Boost Target		$298.00 ➝ $305.00	Low
5/10/2023	Argus	Boost Target		$285.00 ➝ $310.00	Low
4/25/2023	Wells Fargo & Company	Boost Target		$243.00 ➝ $275.00	Low
4/25/2023	Sanford C. Bernstein	Boost Target		$310.00 ➝ $345.00	Low
4/24/2023	Barclays	Boost Target		$256.00 ➝ $275.00	Low
4/24/2023	Truist Financial	Boost Target		$310.00 ➝ $325.00	Low
4/24/2023	Royal Bank of Canada	Boost Target		$283.00 ➝ $315.00	Low
4/24/2023	Jefferies Financial Group	Boost Target		$325.00 ➝ $350.00	Low
4/24/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$280.00 ➝ $310.00	Low
4/24/2023	Loop Capital	Boost Target		$285.00 ➝ $320.00	Low
4/24/2023	Bank of America	Boost Target		$294.00 ➝ $323.00	Low
4/24/2023	Raymond James	Boost Target		$300.00 ➝ $320.00	Low
4/24/2023	Credit Suisse Group	Boost Target		$282.00 ➝ $311.00	Low
4/24/2023	Oppenheimer	Boost Target		$270.00 ➝ $310.00	Low
4/24/2023	Citigroup	Boost Target		$293.00 ➝ $324.00	Low
4/21/2023	Stephens	Reiterated Rating	Overweight	$283.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$304.00	Low
4/19/2023	JPMorgan Chase & Co.	Boost Target	Neutral	$257.00 ➝ $283.00	Low
4/11/2023	Mizuho	Boost Target	Buy	$279.00 ➝ $298.00	Low
3/16/2023	Royal Bank of Canada	Reiterated Rating	Outperform	$283.00	Low
3/13/2023	Stephens	Reiterated Rating	Overweight	$283.00	Low
2/23/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$235.00 ➝ $257.00	Low
2/22/2023	Stephens	Boost Target	Overweight	$275.00 ➝ $283.00	N/A
2/13/2023	Argus	Boost Target	Buy	$260.00 ➝ $285.00	Low
2/8/2023	The Goldman Sachs Group	Boost Target	Buy	$265.00 ➝ $296.00	Low
1/31/2023	Raymond James	Boost Target	Outperform	$230.00 ➝ $300.00	Low
1/30/2023	Loop Capital	Boost Target		$240.00 ➝ $285.00	Low
1/30/2023	Royal Bank of Canada	Boost Target	Outperform	$239.00 ➝ $283.00	Low
1/30/2023	Truist Financial	Boost Target	Buy	$270.00 ➝ $290.00	Low
1/30/2023	Cowen	Boost Target	Outperform	$238.00 ➝ $292.00	Low
1/30/2023	Mizuho	Boost Target	Buy	$265.00 ➝ $279.00	Low
1/30/2023	Citigroup	Boost Target	Buy	$280.00 ➝ $293.00	Low
1/19/2023	Oppenheimer	Boost Target	Outperform	$235.00 ➝ $270.00	Low
1/13/2023	UBS Group	Boost Target	Buy	$237.00 ➝ $296.00	Low
1/3/2023	Wells Fargo & Company	Boost Target	Equal Weight	$217.00 ➝ $243.00	Low
1/3/2023	Truist Financial	Boost Target		$240.00 ➝ $270.00	Low
1/3/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$240.00 ➝ $275.00	Low
12/16/2022	SVB Leerink	Boost Target	Outperform	$238.00 ➝ $286.00	Low
12/14/2022	Mizuho	Boost Target	Buy	$242.00 ➝ $265.00	Low
12/12/2022	The Goldman Sachs Group	Boost Target	Buy	$233.00 ➝ $265.00	Low
11/2/2022	Mizuho	Boost Target	Buy	$230.00 ➝ $242.00	Low
10/27/2022	Credit Suisse Group	Lower Target		$240.00	Low
10/26/2022	Citigroup	Boost Target	Buy	$240.00 ➝ $251.00	Low
10/25/2022	Raymond James	Lower Target	Outperform	$250.00 ➝ $230.00	Low
10/24/2022	Stephens	Lower Target	Overweight	$230.00 ➝ $220.00	Low
10/24/2022	Royal Bank of Canada	Lower Target	Outperform	$249.00 ➝ $239.00	Low
10/24/2022	SVB Leerink	Lower Target	Outperform	$252.00 ➝ $238.00	Low
10/24/2022	Oppenheimer	Lower Target	Outperform	$255.00 ➝ $235.00	Low
10/24/2022	Wells Fargo & Company	Boost Target	Equal Weight	$199.00 ➝ $217.00	Low
9/16/2022	Raymond James	Boost Target	Outperform	$230.00 ➝ $250.00	Low
8/24/2022	SVB Leerink	Boost Target	Outperform	$240.00 ➝ $259.00	Low
8/2/2022	Mizuho	Boost Target	Buy	$210.00 ➝ $230.00	Low
7/26/2022	UBS Group	Boost Target		$227.00	Low
7/26/2022	Citigroup	Lower Target		$254.00 ➝ $240.00	Low
7/25/2022	Stephens	Boost Target		$230.00	Low
7/25/2022	Cowen	Lower Target		$238.00	Low
7/25/2022	Credit Suisse Group	Boost Target	Outperform	$230.00 ➝ $250.00	Low
7/25/2022	SVB Leerink	Boost Target	Outperform	$212.00 ➝ $240.00	Low
7/25/2022	Truist Financial	Boost Target	Buy	$208.00 ➝ $240.00	Low
7/24/2022	Bank of America	Boost Target		$192.00 ➝ $230.00	Low
7/19/2022	Credit Suisse Group	Set Target		$230.00	Low
7/15/2022	SVB Leerink	Lower Target	Outperform	$273.00 ➝ $212.00	Low
7/12/2022	The Goldman Sachs Group	Lower Target	Buy	$270.00 ➝ $233.00	N/A
7/11/2022	Raymond James	Lower Target	Outperform	$245.00 ➝ $220.00	N/A
7/7/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$306.00 ➝ $200.00	N/A
7/6/2022	BMO Capital Markets	Downgrade	Market Perform ➝ Underperform	$233.00 ➝ $160.00	N/A
7/1/2022	Mizuho	Lower Target	Buy	$260.00 ➝ $210.00	Low
6/21/2022	Royal Bank of Canada	Lower Target	Outperform	$267.00 ➝ $256.00	Low
6/20/2022	Oppenheimer	Set Target		$255.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$240.00	Medium
5/26/2022	Sanford C. Bernstein	Upgrade	Market Perform ➝ Outperform	$273.00 ➝ $271.00	Low
5/3/2022	Mizuho	Lower Target		$290.00 ➝ $260.00	Medium
4/26/2022	BMO Capital Markets	Lower Target		$275.00 ➝ $240.00	High
4/26/2022	Raymond James	Lower Target	Outperform	$275.00 ➝ $245.00	High
4/26/2022	UBS Group	Lower Target	Buy	$289.00 ➝ $241.00	High
4/25/2022	Cowen	Lower Target		$265.00 ➝ $241.00	Low
4/25/2022	Truist Financial	Lower Target	Buy	$310.00 ➝ $250.00	Medium
4/25/2022	Jefferies Financial Group	Lower Target		$310.00 ➝ $275.00	Low
4/25/2022	Wells Fargo & Company	Lower Target	Equal Weight	$267.00 ➝ $227.00	Low
4/25/2022	Cowen	Lower Target		$265.00 ➝ $241.00	Low
4/25/2022	SVB Leerink	Lower Target	Outperform	$304.00 ➝ $273.00	Medium
4/25/2022	Royal Bank of Canada	Lower Target	Outperform	$291.00 ➝ $267.00	Low
4/25/2022	Citigroup	Lower Target	Buy	$277.00 ➝ $254.00	Low
4/25/2022	Credit Suisse Group	Lower Target	Outperform	$296.00 ➝ $260.00	Medium
3/28/2022	Wells Fargo & Company	Initiated Coverage	Equal Weight	$267.00	Low
1/28/2022	Cowen	Lower Target	Outperform	$302.00 ➝ $265.00	High
1/28/2022	SVB Leerink	Lower Target	Outperform	$320.00 ➝ $304.00	High
1/5/2022	Truist Financial	Boost Target	Buy ➝ Buy	$290.00 ➝ $310.00	High
12/21/2021	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$270.00	Medium
12/20/2021	Mizuho	Boost Target	Buy	$275.00 ➝ $290.00	High
10/26/2021	Raymond James	Boost Target	Outperform	$290.00 ➝ $300.00	Low
10/25/2021	William Blair	Reiterated Rating	Market Perform		Low
10/25/2021	Stephens	Boost Target	Overweight	$275.00 ➝ $283.00	High
10/25/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$275.00 ➝ $306.00	High
10/25/2021	Citigroup	Boost Target	Neutral	$268.00 ➝ $274.00	High
10/25/2021	Royal Bank of Canada	Boost Target	Outperform	$273.00 ➝ $291.00	High
10/25/2021	Credit Suisse Group	Boost Target	Outperform	$267.00 ➝ $298.00	High
10/25/2021	Oppenheimer	Boost Target	Outperform	$275.00 ➝ $290.00	High
9/27/2021	SVB Leerink	Initiated Coverage	Outperform	$320.00	Low
9/23/2021	UBS Group	Initiated Coverage	Buy	$312.00	Low
9/9/2021	Cowen	Initiated Coverage	Outperform	$293.00	Low
8/27/2021	Barclays	Reiterated Rating	Hold ➝ Neutral		Low
8/12/2021	Barclays	Downgrade	Overweight ➝ Equal Weight	$275.00 ➝ $267.00	Low
8/6/2021	The Goldman Sachs Group	Boost Target	Buy	$252.00 ➝ $279.00	Low
7/22/2021	Barclays	Boost Target	Overweight	$225.00 ➝ $275.00	Low
7/21/2021	Truist Financial	Boost Target	Buy	$260.00 ➝ $290.00	Medium
7/21/2021	Credit Suisse Group	Boost Target	Outperform	$222.00 ➝ $267.00	Low
7/21/2021	Mizuho	Boost Target	Buy	$232.00 ➝ $275.00	Low
7/21/2021	Raymond James	Boost Target	Outperform	$225.00 ➝ $290.00	Low
7/21/2021	Royal Bank of Canada	Boost Target	Outperform	$247.00 ➝ $273.00	Low
7/21/2021	Oppenheimer	Boost Target	Outperform	$230.00 ➝ $275.00	Low
7/21/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$225.00 ➝ $275.00	Low
7/21/2021	BMO Capital Markets	Boost Target	Market Perform	$235.00 ➝ $250.00	Low
7/21/2021	Citigroup	Boost Target	Neutral	$215.00 ➝ $268.00	Low
7/19/2021	The Goldman Sachs Group	Boost Target	Buy	$223.00 ➝ $252.00	Low
7/9/2021	Seaport Res Ptn	Reiterated Rating	Buy		Low
6/18/2021	Jefferies Financial Group	Reiterated Rating	Buy		High
4/29/2021	Raymond James	Reiterated Rating	Outperform	$190.00 ➝ $225.00	Medium
4/29/2021	Royal Bank of Canada	Boost Target	Outperform	$205.00 ➝ $232.00	N/A
4/29/2021	Mizuho	Boost Target	Buy	$205.00 ➝ $232.00	N/A
4/26/2021	Citigroup	Downgrade	Buy ➝ Neutral		Low
4/26/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$210.00 ➝ $225.00	Low
4/26/2021	BMO Capital Markets	Boost Target	Market Perform	$200.00 ➝ $222.00	Low
4/23/2021	Raymond James	Boost Target	Outperform	$190.00 ➝ $225.00	Low
4/23/2021	Oppenheimer	Boost Target	Outperform	$200.00 ➝ $230.00	Low
4/23/2021	Barclays	Boost Target	Overweight	$195.00 ➝ $225.00	High
4/23/2021	Mizuho	Boost Target	Buy	$205.00 ➝ $232.00	High
4/23/2021	Royal Bank of Canada	Boost Target	Outperform	$205.00 ➝ $232.00	High
4/19/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$210.00 ➝ $225.00	N/A
4/14/2021	Truist Financial	Boost Target	Buy	$200.00 ➝ $230.00	Low
4/13/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$180.00 ➝ $210.00	Medium
4/9/2021	Mizuho	Boost Target	Buy	$195.00 ➝ $205.00	Medium
2/5/2021	Mizuho	Boost Target	Buy	$180.00 ➝ $195.00	Medium
2/4/2021	UBS Group	Boost Target	Buy	$164.00 ➝ $203.00	High
2/3/2021	Citigroup	Boost Target		$185.00 ➝ $191.00	Low
2/3/2021	Credit Suisse Group	Boost Target	Outperform	$197.00 ➝ $201.00	High
2/3/2021	Raymond James	Boost Target	Outperform	$150.00 ➝ $190.00	High
1/5/2021	Truist Financial	Boost Target		$165.00 ➝ $190.00	N/A
1/5/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$150.00 ➝ $180.00	N/A
12/18/2020	Mizuho	Boost Target	Buy	$170.00 ➝ $180.00	Low
12/15/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$191.00	Medium
12/14/2020	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight	$143.00 ➝ $194.00	High
12/7/2020	Mizuho	Boost Target	Buy	$150.00 ➝ $170.00	Medium
11/11/2020	Piper Sandler	Boost Target	Overweight	$149.00 ➝ $163.00	High
10/27/2020	Smith Barney Citigroup	Boost Target		$142.00 ➝ $155.00	Medium
10/27/2020	Piper Sandler	Boost Target	Neutral	$138.00 ➝ $149.00	High
10/27/2020	Raymond James	Boost Target	Outperform	$140.00 ➝ $150.00	High
10/27/2020	Credit Suisse Group	Boost Target	Outperform	$158.00 ➝ $164.00	High
10/27/2020	Mizuho	Boost Target	Buy	$145.00 ➝ $150.00	High
10/27/2020	Barclays	Boost Target	Overweight	$140.00 ➝ $150.00	High
10/9/2020	CSFB	Boost Target	Outperform	$143.00 ➝ $158.00	Medium
10/9/2020	Credit Suisse Group	Boost Target	Outperform	$143.00 ➝ $158.00	High
9/21/2020	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$161.00 ➝ $143.00	High
9/16/2020	Truist Financial	Boost Target	Buy	$150.00 ➝ $165.00	Low
7/24/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$142.00 ➝ $161.00	Low
7/23/2020	Oppenheimer	Boost Target		$135.00 ➝ $140.00	High
7/23/2020	Deutsche Bank Aktiengesellschaft	Boost Target		$132.00 ➝ $150.00	Medium
7/23/2020	Piper Sandler	Boost Target	Neutral	$132.00 ➝ $138.00	Low
7/23/2020	Raymond James	Boost Target	Cautious ➝ Outperform	$130.00 ➝ $140.00	High
7/23/2020	SunTrust Banks	Boost Target	Buy	$130.00 ➝ $150.00	High
7/23/2020	Mizuho	Boost Target	Buy	$136.00 ➝ $145.00	High
7/23/2020	Citigroup	Boost Target	Buy	$131.00 ➝ $142.00	High
7/13/2020	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$121.00 ➝ $100.00	Low
6/11/2020	UBS Group	Lower Target	Buy	$138.00 ➝ $137.00	High
5/29/2020	Mizuho	Lower Target	Buy	$150.00 ➝ $136.00	High
5/20/2020	Citigroup	Lower Target	Buy	$168.00 ➝ $131.00	Medium
4/27/2020	UBS Group	Lower Target	Buy	$183.00 ➝ $138.00	Low
4/22/2020	SunTrust Banks	Lower Target	Buy	$160.00 ➝ $140.00	Medium
4/22/2020	Barclays	Boost Target	Overweight	$117.00 ➝ $127.00	Medium
4/22/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$165.00 ➝ $132.00	Medium
4/22/2020	Oppenheimer	Lower Target	Outperform	$160.00 ➝ $135.00	Medium
4/20/2020	Raymond James	Lower Target	Outperform	$165.00 ➝ $130.00	High
4/13/2020	SunTrust Banks	Lower Target	Buy	$185.00 ➝ $160.00	High
3/25/2020	Barclays	Reiterated Rating	Buy	$117.00	High
3/19/2020	Credit Suisse Group	Reiterated Rating	Buy	$173.00	Low
2/3/2020	Barclays	Boost Target	Overweight ➝ Positive	$172.00 ➝ $177.00	Low
1/29/2020	SunTrust Banks	Reiterated Rating	Buy	$185.00	Medium
1/29/2020	Robert W. Baird	Boost Target	Outperform	$160.00 ➝ $180.00	Low
1/29/2020	Credit Suisse Group	Boost Target	Outperform	$169.00 ➝ $173.00	Low
1/29/2020	Stephens	Boost Target	Overweight	$175.00 ➝ $180.00	Medium
1/29/2020	Citigroup	Boost Target	Buy	$156.00 ➝ $168.00	Medium
1/29/2020	Royal Bank of Canada	Boost Target	Outperform	$170.00 ➝ $173.00	Medium
1/27/2020	The Goldman Sachs Group	Reiterated Rating	Buy	$165.00	High
1/3/2020	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$140.00	Low
12/20/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$157.00 ➝ $186.00	Low
12/6/2019	Bank of America	Upgrade	Neutral ➝ Buy		High
10/30/2019	Barclays	Boost Target	Overweight	$145.00 ➝ $155.00	Low
9/6/2019	Bank of America	Upgrade	Underperform ➝ Neutral	$130.00 ➝ $137.00	Medium
8/7/2019	Stephens	Set Target	Buy	$150.00	Low
7/31/2019	Mizuho	Set Target	Buy	$153.00	N/A
7/10/2019	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$147.00 ➝ $160.00	Low
6/24/2019	UBS Group	Boost Target	Buy	$172.00 ➝ $181.00	Medium
5/1/2019	UBS Group	Boost Target	Buy ➝ Buy	$164.00 ➝ $172.00	Low
5/1/2019	Deutsche Bank Aktiengesellschaft	Boost Target	Buy ➝ Buy	$160.00 ➝ $165.00	Medium

(Data available from 4/26/2019 forward)

News Sentiment Rating

0.69 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

30 very positive mentions
20 positive mentions
6 negative mentions
1 very negative mentions

Mentions as of

9/29/2023

22 very positive mentions
36 positive mentions
6 negative mentions
8 very negative mentions

Mentions as of

10/29/2023

11 very positive mentions
19 positive mentions
9 negative mentions
5 very negative mentions

Mentions as of

11/28/2023

24 very positive mentions
20 positive mentions
7 negative mentions
10 very negative mentions

Mentions as of

12/28/2023

30 very positive mentions
23 positive mentions
6 negative mentions
2 very negative mentions

Mentions as of

1/27/2024

51 very positive mentions
57 positive mentions
6 negative mentions
4 very negative mentions

Mentions as of

2/26/2024

35 very positive mentions
30 positive mentions
6 negative mentions
2 very negative mentions

Mentions as of

3/27/2024

33 very positive mentions
41 positive mentions
6 negative mentions
0 very negative mentions

Mentions as of

4/26/2024

Current Sentiment

Recent Stories by Sentiment

Very Negative

No very negative mentions tracked during this time.

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Today's Range

Now: $306.60

$295.79

$307.27

50 Day Range

MA: $323.94

$297.00

$333.53

52 Week Range

Now: $306.60

$215.96

$335.83

Volume

2,257,039 shs

Average Volume

1,107,586 shs

Market Capitalization

$81.09 billion

P/E Ratio

16.15

Dividend Yield

0.83%

Beta

1.65

Frequently Asked Questions

What sell-side analysts currently cover shares of HCA Healthcare?: The following sell-side analysts have issued research reports on HCA Healthcare in the last year: 1-800-FLOWERS.COM, Inc., Argus, Barclays PLC, Cantor Fitzgerald, Citigroup Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Mizuho, Oppenheimer Holdings Inc., Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stephens, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., VNET Group, Inc., and Wells Fargo & Company.
View the latest analyst ratings for HCA.
What is the current price target for HCA Healthcare?: 16 Wall Street analysts have set twelve-month price targets for HCA Healthcare in the last year. Their average twelve-month price target is $310.88, suggesting a possible upside of 1.4%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting HCA will reach $359.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $265.00 for HCA Healthcare in the next year.
View the latest price targets for HCA.
What is the current consensus analyst rating for HCA Healthcare?: HCA Healthcare currently has 4 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for HCA.
What other companies compete with HCA Healthcare?: Other companies that are similar to HCA Healthcare include GSK, Gilead Sciences, Regeneron Pharmaceuticals, McKesson and Bristol-Myers Squibb. Learn More about companies similar to HCA Healthcare.
How do I contact HCA Healthcare's investor relations team?: HCA Healthcare's physical mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company's listed phone number is (615) 344-9551 and its investor relations email address is [email protected]. The official website for HCA Healthcare is www.hcahealthcare.com. Learn More about contacing HCA Healthcare investor relations.

HCA Healthcare - HCA Stock Price Target and Predictions

Analyst Price Target for HCA

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.69 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of HCA Healthcare?

What is the current price target for HCA Healthcare?

What is the current consensus analyst rating for HCA Healthcare?

What other companies compete with HCA Healthcare?

How do I contact HCA Healthcare's investor relations team?